MedPath

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Obsessive-Compulsive Disorder

Withdrawn
Conditions
Obsessive-Compulsive Disorder
Registration Number
NCT04211402
Lead Sponsor
ProgenaBiome
Brief Summary

This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records.

Detailed Description

The goal of this Research Study is to better understand how the genetic information in subject's microbiome correlates to infection with Obsessive-Compulsive Disorder.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  1. Signed informed consent, demonstrating that the patient understands the procedures required for the study and the purpose of the study

    a. May be signed by parent or legal guardian in the case of minor or adult unable to provide consent

  2. Male or female of all ages

  3. OCI greater than or equal to 21

Exclusion Criteria
  1. Refusal to sign informed consent form
  2. History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy.
  3. Postoperative stoma, ostomy, or ileoanal pouch
  4. Participation in any experimental drug protocol within the past 12 weeks
  5. Treatment with total parenteral nutrition

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Correlation of Microbiome to Disease via Relative Abundance Found in Microbiome SequencingThree years

Relative abundance of bacterial classes within taxonomic phyla and, more broadly, within their domain will be analyzed by sequencing the gut microbiome. These data will then be categorized with Obsessive-Compulsive Disorder

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

ProgenaBiome

🇺🇸

Ventura, California, United States

ProgenaBiome
🇺🇸Ventura, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.